Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 2.7× sales vs its 2.8× historical median P/S.
Fair value ≈ $66.50 · price $63.48 today
Fair value · 5% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Investors can still file late claims for the $78M $CTLT settlement.
If you bought Catalent shares between 2021 - 2023, you actually have a chance to recover your losses: https://11th.com/cases/catalent-investors-case
Don't forget that there is also an important settlement to watch for $CTLT
We have every detail, including how investors can get paid: https://11th.com/cases/catalent-investors-case
[FAQ] Everything you need to know about the $78 million $CTLT Settlement
Q: What happened?
A: Catalent has agreed to settle $78 million with investors to resolve claims that it overstated customer demand and financial guidance, and concealed serious production issues.
Q: Am I actually eligible?
A: If you bought $CTLT shares between August 30, 2021, through May 7, 2023, you’re likely eligible. You don’t need to hold the stock still to claim; past losses count
Q: How much will I actually get?
A: The current estimated payout is $0.61 per share. The final amount depends on how many people file; if fewer people claim, the payout per share can actually increase for those who did
Q: When do payouts happen?
A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
Q: I missed the deadline. Is it too late?
A: Not necessarily! We are currently processing 'Late-but-Valid' claims. The court often accepts these as long as the fund hasn't been distributed yet.
Q: Is my data safe with 11th Estate?
A: Security is our top priority. We use bank-level encryption and are SOC2-compliant. We only process the trade data required for the court audit, and your personal financial credentials stay private.
Q: What is the fee?
A: We work on a 20% success fee. We handle the math, the paperwork, and the filing. If you don't get a payout, you don't pay us a cent.
Q: How do I start?
A: Just click the link below to submit your claim through our secure portal.
https://11th.com/cases/catalent-investors-case
$CTLT Don't forget that there is also an important settlement to watch for $CTLT.
We have every detail, including how investors can get paid: https://11th.com/cases/catalent-investors-case
$CTLT Settlement Deadline is next week (May 26, 2026)
If you bought shares between August 30, 2021 and May 7, 2023, you may qualify for the $78 million settlement.
The case alleged that Catalent misled investors about overstated customer demand and financial guidance, and concealed serious production issues. After the disclosure, the stock dropped 70%, and the company later agreed to compensate shareholders.
File your claim here: https://11th.com/cases/catalent-investors-case
The $78 million Catalent ($CTLT) deadline is May 26, 2026.
If you held shares between August 30, 2021, and July 5, 2023, you are likely eligible for the $78 million recovery fund.
This settlement resolves claims that Catalent misled investors regarding overstating customer demand and financial guidance and concealing serious production issues. The stock dropped 70% following the disclosure, and now the company is paying back the impacted shareholders ($0.61 per share).
File your claim here: https://11th.com/cases/catalent-investors-case
$CTLT investors, if you follow us, you already know about it.
This info hits different after the news. Check it out: https://11th.com/cases/catalent-investors-case
$CTLT investors — there's no hidden secret here. Just one thing you really need to know.
Here's how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/catalent-investors-case
Health Secretary RFK Jr plans to loosen restrictions on some peptides that the FDA previously prohibited compounding pharmacies from producing
Kennedy wants to unban 14 of the 19 peptides that were placed on an FDA "do not formulate" list in 2023
Many physicians argue that many of them don't have sufficient evidence behind them to prove that they're safe & that they work
https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
When the FDA added those peptides to its do-not-compound list, wellness entrepreneurs & compounding pharmacies pushed back, w/ some filing lawsuits against the FDA
Kennedy blamed litigation for allowing him to only reinstate 14 of the 19 peptides that had been added to the list
$MCK $COR $HIMS - $IPN $CTLT
Imagine buying $CTLT at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back.
To all $CTLT investors out there, we’ve got some important news for you: https://11th.com/cases/catalent-investors-case
$CTLT has reached a $78,000,000 settlement with $CTLT investors over claims that it overstated customer demand and financial guidance, and concealed serious production issues.
The filing deadline is May 26, 2026. If you bought $CTLT between August 30, 2021 and May 7, 2023, you can file for payment here: https://11th.com/cases/catalent-investors-case
$CTLT has reached a $78,000,000 settlement with $CTLT investors over claims that it overstated customer demand and financial guidance while concealing serious production issues.
The filing deadline is May 26, 2026. If you bought $CTLT between August 30, 2021 and May 7, 2023, you can file for payment here: https://11th.com/cases/catalent-investors-case
Imagine buying $CTLT at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back.
To all $CTLT investors out there, we’ve got some important news for you: https://11th.com/cases/catalent-investors-case
$CTLT has agreed to settle with investors over claims that it misled them about customer demand, financial guidance, and production issues.
Who’s eligible?
Anyone who purchased $CTLT shares between August 30, 2021 and May 7, 2023.
Do I need to sell my shares to qualify?
No — you are eligible whether you sold your shares or still hold them.
How much is the payout?
The payout per share is $0.61 — but if only ~25% of eligible investors file, the effective payout could increase to $2.44.
Can I still file?
Claim availability depends on the settlement administrator’s approval process.
When do payouts happen?
Typically within 8–12 months after court approval of the settlement.
To file your claim: https://11th.com/cases/catalent-investors-case
